Therapeutic targeting of polo-like kinase 1 using RNA-interfering nanoparticles (iNOPs) for the treatment of non-small cell lung cancer

Non-small cell lung cancer (NSCLC) remains the most common cause of cancer death worldwide due its resistance to chemotherapy and aggressive tumor growth. Polo-like kinase 1 (PLK1) is a serine-threonine protein kinase which is overexpressed in cancer cells, and plays a major role in regulating tumor...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: McCarroll, Joshua A., Dwarte, Tanya, Baigude, Huricha, Dang, Jason, Yang, Lu, Erlich, Rafael B., Kimpton, Kathleen, Teo, Joann, Sagnella, Sharon M., Akerfeldt, Mia C., Liu, Jie, Phillips, Phoebe A., Rana, Tariq M., Kavallaris, Maria
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2015
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4494920/
https://ncbi.nlm.nih.gov/pubmed/25557168
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados